• Immune-related adverse events manageable with vigilance, appropriate treatment

    4 monthes ago - By Healio

    NEW YORK - Advances in immunotherapy have transformed cancer treatment but require clinicians to be vigilant for adverse events, according to a presenter at Chemotherapy Foundation Symposium.
    “The list of cancers for which these drugs are approved is ever increasing, and we're starting to use these therapies in earlier lines. As more patients are exposed to them, we have to be more aware of the toxicities and how to best manage them,” Richard D. Carvajal, MD, director of experimental therapeutics, director of the melanoma service and associate director of translational
    Read more ...